Cargando…
Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications
Cytokine release syndrome (CRS) is a major cause of the multi-organ injury and fatal outcome induced by SARS-CoV-2 infection in severe COVID-19 patients. Metabolism can modulate the immune responses against infectious diseases, yet our understanding remains limited on how host metabolism correlates...
Autores principales: | Xiao, Nan, Nie, Meng, Pang, Huanhuan, Wang, Bohong, Hu, Jieli, Meng, Xiangjun, Li, Ke, Ran, Xiaorong, Long, Quanxin, Deng, Haijun, Chen, Na, Li, Shao, Tang, Ni, Huang, Ailong, Hu, Zeping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955129/ https://www.ncbi.nlm.nih.gov/pubmed/33712622 http://dx.doi.org/10.1038/s41467-021-21907-9 |
Ejemplares similares
-
Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
por: Liu, Zhijun, et al.
Publicado: (2021) -
Immunometabolic reprogramming, another cancer hallmark
por: Kumar, Vijay, et al.
Publicado: (2023) -
Effects of PD-1 Signaling on Immunometabolic Reprogramming
por: Boussiotis, Vassiliki A., et al.
Publicado: (2022) -
Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020) -
Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record
por: Shi, Zongqi, et al.
Publicado: (2022)